Clinical significance of breast cancer susceptibility gene 1 expression in resected non-small cell lung cancer: A meta-analysis

Table 2 Correlations of breast cancer susceptibility gene 1 expression with clinicopathological characteristics in resected non-small cell lung cancer

Ref.	Gender (M vs F)	Age (≥ 60 vs < 60)	Tumor size (T3/4 vs T1/2)	TNM stage (III /IV vs I/II)	Histology (AC vs SCC)	Differentiation (poor vs moderate/well)
Rosell et al[18]	-	-	-	-		-
Bartolucci et al[11]	-	-	-	-		-
Ma et al[19]	1.050 (0.740-1.489)	-	1.046 (0.734-1.489)	-	0.916 (0.636-1.319)	1.204 (0.860-1.687)
Leng et al[20]	-	-	-	-	-	-
Gachechiladze et al[21]	-	-	-	0.920 (0.454-1.861)	-	-
Gachechiladze et al[21]	0.857 (0.608-1.210)	1.273 (0.917-1.768)	-	1.020 (0.727-1.433)	0.990 (0.704-1.392)	1.238 (0.890-1.723)
Yu et al[22]	-	-	-	-	-	-
Grossi et al[23]	-	-	-	-	-	-
Lafuente-Sanchis et al[24]	0.829 (0.265-2.592)	0.367 (0.050-2.678)	-	3.375 (0.776-14.678)	1.660 (0.383-7.204)	-
Huang et al[12]	-	-	-	-	-	-
Wang et al[25]	0.948 (0.735-1.224)	0.889 (0.711-1.112)	-	-	-	-
Overall	0.94 (0.79-1.12), P = 0.522; I2 = 0.0, P = 0.871	1.01 (0.72-1.42), P = 0.948; I2 = 51.2, P = 0.129	-	1.05 (0.78-1.42), P = 0.739; I2 = 22.7, P = 0.274	0.97 (0.76-1.24), P = 0.806; I2 = 0.0, P = 0.732	1.22 (0.97-1.55), P = 0.097; I2 = 0.0, P = 0.908

M: Male; F: Female; TNM: Tumor-node-metastasis; AC: Adenocarcinoma; SCC: Squamous cell carcinoma.